Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ZNF154 gene

Known as: ZINC FINGER PROTEIN 154, ZNF154, pHZ-92 
 
National Institutes of Health

Related topics

Related topics

1 relation
Zinc Fingers

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Survival Analysis of Multi-Omics Data Identifies Potential Prognostic Markers of Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is the most common and among the deadliest of pancreatic cancers. Its 5-year survival is… Expand
2018
2018
ZNF154 is a promising diagnosis biomarker and predicts biochemical recurrence in prostate cancer.
OBJECTIVE To screen the methylated genes for early diagnosis and biochemical recurrence (BCR) prediction in prostate cancer (PCa… Expand
2017
2017
Candidate tumor suppressor ZNF154 suppresses invasion and metastasis in NPC by inhibiting the EMT via Wnt/β-catenin signalling
Background Nasopharyngeal carcinoma (NPC) is especially prevalent in southeast Asia and southern China, but its molecular… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
2016
2016
An epigenetic biomarker combination of PCDH17 and POU4F2 detects bladder cancer accurately by methylation analyses of urine sediment DNA in Han Chinese
To develop a routine and effectual procedure of detecting bladder cancer (BlCa), an optimized combination of epigenetic… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2016
2016
Robust Detection of DNA Hypermethylation of ZNF154 as a Pan-Cancer Locus with in Silico Modeling for Blood-Based Diagnostic Development.
Sites that display recurrent, aberrant DNA methylation in cancer represent potential biomarkers for screening and diagnostics… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2014
2014
Prognostication of patients with clear cell renal cell carcinomas based on quantification of DNA methylation levels of CpG island methylator phenotype marker genes
BackgroundThe CpG island methylator phenotype (CIMP) of clear cell renal cell carcinomas (ccRCCs) is characterized by… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
2013
2013
Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines
The study of aberrant DNA methylation in cancer holds the key to the discovery of novel biological markers for diagnostics and… Expand
Highly Cited
2012
Highly Cited
2012
Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation
Background Non muscle invasive bladder cancer (NMIBC) has the highest recurrence rate of any malignancy and as many as 70% of… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Highly Cited
2012
Highly Cited
2012
Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas
To clarify the significance of DNA methylation alterations during renal carcinogenesis, methylome analysis using single-CpG… Expand
  • figure 1
  • table II
  • figure 2
  • table III
  • table III
Highly Cited
2011
Highly Cited
2011
Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers
Purpose: Epigenetic alterations are common and can now be addressed in a parallel fashion. We investigated the methylation in… Expand
  • table 1
  • table 2
  • table 4
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE